Mar 4, 2026 08:00AM
Mar 4, 2026 08:00AM
Feb 3, 2026 07:31AM
Feb 3, 2026 07:30AM
Oct 24, 2025 07:30AM
Oct 24, 2025 07:30AM
Oct 16, 2025 07:30AM MIRA Pharmaceuticals reports oral Mira-55 outperformed morphine in pain study
Oct 16, 2025 07:30AM
Sep 30, 2025 07:31AM
Sep 30, 2025 07:30AM
Sep 22, 2025 08:02AM
Sep 22, 2025 08:00AM
Sep 16, 2025 07:30AM
Sep 16, 2025 07:30AM MIRA Pharmaceuticals Reports Positive PTSD Data Demonstrating Ketamir-2 Restores Normalized Behavior in Stressed Animals
Sep 12, 2025 07:30AM
Sep 12, 2025 07:30AM
Aug 19, 2025 08:30AM
Aug 19, 2025 08:30AM
Aug 12, 2025 08:32AM
Aug 12, 2025 08:30AM
Jul 30, 2025 07:30AM MIRA Pharmaceuticals topical Ketamir-2 matches morphine in preclinical study
Jul 30, 2025 07:30AM
Jul 29, 2025 07:31AM
Jul 29, 2025 07:30AM
Jul 11, 2025 08:00AM
Jul 11, 2025 08:00AM
Jul 3, 2025 08:02AM
Jul 3, 2025 08:00AM MIRA Reports Potent Inflammatory Pain Relief from Non-Psychoactive Marijuana Analog Mira-55 in Animal Model, Matching Morphine Without Opioid Risks
Jun 30, 2025 08:00AM
Jun 25, 2025 08:00AM
Jun 18, 2025 08:31AM
Jun 18, 2025 08:30AM
Jun 17, 2025 04:06PM
May 28, 2025 08:30AM
May 8, 2025 08:04AM Mira Pharma (MIRA) Announces Board Approval of SKNY Acquisition
May 8, 2025 08:00AM
May 6, 2025 08:02AM
May 6, 2025 08:00AM
Apr 23, 2025 08:04AM
Apr 23, 2025 08:00AM
Apr 16, 2025 08:03AM
Apr 16, 2025 08:00AM MIRA Pharmaceuticals Announces Positive Results for Ketamir-2 in Diabetic Neuropathy Animal Model, Reinforcing Confidence Ahead of Phase I Completion
Apr 1, 2025 08:00AM
Mar 24, 2025 07:33AM
Mar 24, 2025 07:30AM
Jun 8, 2016 08:01AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All